Takeda Pharmaceutical Company Limited Share Price
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
07:30:00 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 5,847.00 JPY | +1.92% |
|
+1.51% | +20.93% |
| Market Cap | 9,161B 59.26B 51.35B 48.46B 43.96B 82.47B 5,680B 83.07B 579B 223B 2,881B 223B 218B | P/E 2027 * |
45.4x | P/E 2028 * | 28.9x |
|---|---|---|---|---|---|
| Enterprise Value | 13,067B 84.53B 73.25B 69.12B 62.71B 118B 8,102B 118B 826B 318B 4,110B 317B 311B | EV / Sales 2027 * |
2.78x | EV / Sales 2028 * | 2.69x |
| Free-Float |
99.26% | Yield 2027 * |
3.56% | Yield 2028 * | 3.63% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
Tradegate
| TKD | Real-time | |
|
OTC Markets
| TKPHF | Delayed | |
|
Deutsche Boerse AG
| TKD | Delayed | |
|
Boerse Muenchen
| TKD | Real-time | |
|
Börse Stuttgart
| TKD | Delayed | |
|
Wiener Boerse
| TKD | End-of-day quote |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +1.92% | ||
| 1 week | +1.51% | ||
| Current month | +1.42% | ||
| 1 month | +6.06% | ||
| 3 months | +14.92% | ||
| 6 months | +1.92% | ||
| Current year | +20.93% |
| 1 week | 5,557 |  | 5,884 |
| 1 month | 5,504 | | 5,917 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/2024 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 31/03/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 31/05/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 31/12/2018 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 31/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Sell | Chief Technology Officer | -116,191 | 0.0073% | ||
| 19/08/26 | Sell | Chief Technology Officer | -19,651 | 0.0012% | ||
| 18/08/26 | Sell | Head of Human Resources | -12,980 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.92% | +1.51% | +30.98% | +20.31% | 59.26B | |
| +2.02% | -0.96% | +50.69% | +92.40% | 1,015B | |
| +0.28% | -3.24% | +49.57% | +62.65% | 642B | |
| +1.81% | +2.07% | +19.89% | +70.38% | 463B | |
| -1.00% | +2.17% | +37.52% | +37.02% | 353B | |
| +0.18% | +1.95% | +16.71% | +23.54% | 265B | |
| -1.11% | +1.36% | +5.47% | +10.04% | 254B | |
| +1.10% | -12.75% | +38.03% | +45.44% | 206B | |
| -1.17% | -4.95% | -21.84% | -58.36% | 191B | |
| +1.87% | -3.04% | +27.81% | +89.26% | 182B | |
| Average | +0.43% | -3.09% | +25.48% | +39.27% | 362.95B | |
| Weighted average by Cap. | +0.63% | -2.18% | +33.63% | +56.20% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,701B 30.41B 26.35B 24.87B 22.56B 42.32B 2,915B 42.63B 297B 114B 1,479B 114B 112B | 4,781B 30.93B 26.8B 25.29B 22.95B 43.05B 2,965B 43.36B 302B 116B 1,504B 116B 114B |
| Net income | 196B 1.27B 1.1B 1.04B 943M 1.77B 122B 1.78B 12.41B 4.78B 61.81B 4.77B 4.67B | 322B 2.09B 1.81B 1.71B 1.55B 2.9B 200B 2.92B 20.37B 7.85B 101B 7.83B 7.66B |
| Net Debt | 3,907B 25.27B 21.9B 20.67B 18.75B 35.17B 2,422B 35.42B 247B 95.1B 1,229B 94.92B 92.83B | 3,702B 23.95B 20.75B 19.58B 17.77B 33.33B 2,296B 33.57B 234B 90.13B 1,165B 89.95B 87.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | JP¥5,847.00 | +1.92% | 4,665,400 |
| 14/09/26 | JP¥5,737.00 | +1.25% | 2,846,900 |
| 11/09/26 | JP¥5,666.00 | +0.16% | 4,255,100 |
| 10/09/26 | JP¥5,657.00 | +0.75% | 4,493,300 |
| 09/09/26 | JP¥5,615.00 | -2.52% | 5,530,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
